Statins Plus Exercise: New Study Questions the Combination
June 17, 2013
Simvastatin 40 mg once daily can attenuate increases in cardiorespiratory fitness in response to exercise training.
Cardiology Now
Women and Heart Disease: Incidence, Prevalence, Progress, and the Future
April 6, 2013
Female CV mortality lags behind male mortality; lifetime risk assessment, not 10-year risk, is a better estimation tool for women
The Mediterranean Diet in Primary Cardiovascular Prevention
March 20, 2013
Patients who consumed a Mediterranean-style diet had a 30% reduction in major cardiovascular events compared with patients who ate a diet low in saturated fat.
DPP-4 Antagonists: Benefits, Risks, and the Future
February 26, 2013
Dipeptidyl peptidase-4 inhibitors, of the incretin class of antidiabetes drugs, are weight neutral, avoid hypoglycemia, and result in an average reduction in HbA1c of 0.5% to 1.0%
Lipid-lowering Injectable Antibodies: The Next Big Thing?
November 29, 2012
PCSK-9 inhibition in patients with recalcitrant hypercholesterolemia has reaped reductions in LDL-C of up to 85% after the first week of therapy.
AHA 2012 Highlights: Multivitamins, Omega-3s, the Polypill, and More
November 19, 2012
Platelet function monitoring and adjustment of treatment based on results after coronary stenting does not improve clinical outcomes . . . and other findings from the AHA Scientific Sessions.
Who Needs Beta-Blockers? Analysis Raises Questions
October 24, 2012
A new analysis of data from a large international registry finds that use of beta-blockers in patients with and without a history of coronary artery disease does not reduce cardiovascular events.
Myocardial Infarction: New Meaning, Same Name
October 13, 2012
In 2000, MI was defined as any necrosis in the setting of myocardial ischemia. The 2007 update to this definition recognized that different conditions can lead to myocardial necrosis and 5 types of myocardial infarctions were defined.
Omega-3 Fatty Acid Therapy: What Comes Next?
August 22, 2012
Omega-3 fatty acids used to treat patients with dysglycemia in the ORIGIN trial failed to reduce cardiovascular death or ischemic events. Follow-up was 6 years.
Systemic Inflammation and Use of Diet to Stem Disease
August 3, 2012
The popular media recently took a look at the connection between systemic inflammation and the many human diseases it’s responsible for. A lengthy article in the Wall Street Journal focused on the role of daily diet in the development and modulation of inflammation and noted the clinical use of biomarker C-reactive protein to measure inflammation levels. Harvard cardiologist Christopher Cannon offered tips on eating to beat inflammation and shed pounds at the same time from his new book titled The Complete Idiot’s Guide to the Anti-Inflammation Diet. Alarming health news paired with a new book on diet can create a perfect storm of questions from you patients.
